Myoblasts for Survive 16 Weeks after Intracardiac Transfer and Start Differentiation

Thoracic and Cardiovascular Surgeon

Volumn 51, Issue 6, 2003, Pages 295-300

  Gulbins, Helmut ^a   Pritisanac, A ^a   Anderson, I ^a   Uhlig, A ^a   Goldemund, A ^a   Daebritz, S ^a   Meiser, B ^a   Reichart, B ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Myoblast differentiation; Myoblast transfer; Myoblast transplantation; Myocardial repair

Indexed keywords

CONNEXIN 43; DESMIN; FLUORESCENT DYE; MYOD1 PROTEIN; MYOSIN LIGHT CHAIN KINASE INHIBITOR; NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL LABELING; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; FLUORESCENCE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE; HEART MUSCLE CELL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; MUSCLE FIBRIL; MYOBLAST; MYOFILAMENT; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

EID: 0346788731     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45418     Document Type: Article

References (15)

1. Walsh FS. N-cam is a target cell surface antigen for the purification of muscle cells for myoblast transfer therapy. In: Griggs R, Karpati G (eds). Myoblast Transfer Therapy. New York: Plenum Press, 1990
2. Cifuentes-Diaz C, Nicolet M, Goudou D, Rieger F, Mege RM. N-cadherin and n-cam mediated adhesion in development and regeneration of skeletal muscle. Neuromusc Dis 1993; 3: 361-365
3. Chiu RC-J, Zibaitis A, Kao RL. Cellular Cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60: 12-18
4. Murry CE, Wideman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996; 98: 2512-2523
5. Greentree D, Marelli D, Ma F, Chiu RC-J. Satellite cell transplantation for myocardial repair: labelling techniques. Transplant Proc 1994; 26: p3357
6. Zibaitis A, Greentree D, Ma F, Marelli D, Duong M, Chiu RC-J. Myocardial regeneration with satellite cell transplantation. Transplant Proc 1994; 26: p3294
7. Atkins BZ, Lewis CW, Kraus WE, Hutcheson KA, Glower DD, Taylor DA. Intrcardiac transplantation of skeletal myoblast yields two populations of striated cells in situ. Ann Thorac Surg 1999; 67: 124-129
8. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine 1998; 4: 929-933
9. Dorfman J, Duong M, Zibaitis A, Pelletier MP, Shum-Tim D, Li C, Chiu RC-J. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998; 116: 744-751
10. Koh GY, Klug M, Soonpa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in hearts. J Clin Invest 1993; 92: 1548-1554
11. Yoon PD, Kao RL, Magovern GJ. Myocardial regeneration. Tex Heart Inst J 1995; 22: 119-125
12. Suzuki K, Murtuza B, Heslop L, Morgan JE, Smolenski RT, Suzuki N, Partridge TA, Yacoub MH. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg 2002; 123: 984-992
13. Suzuki K, Brand NJ, Allen S, Khan MA, Farrell AO, Murtuza B, Oakley RE, Yacoub MH. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart. J Thorac Cardiovasc Surg 2001: 122: 759-766
14. Pouzet B, Ghostine S, Vilquin JT, Garcin I, Scorsin M, Hagege AA, Duboc D, Schwartz K, Menasche P. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 2001; 104: 1223-1228
15. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-280